{"id":39094,"date":"2026-06-01T13:32:11","date_gmt":"2026-06-01T11:32:11","guid":{"rendered":"https:\/\/ggba.swiss\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/"},"modified":"2026-06-01T13:36:05","modified_gmt":"2026-06-01T11:36:05","slug":"mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/","title":{"rendered":"MindMaze l\u00e8ve CHF 8 millions pour d\u00e9ployer sa plateforme neuroth\u00e9rapeutique"},"content":{"rendered":"\n<p><a href=\"https:\/\/mindmazetherapeutics.com\/\">MindMaze Therapeutics<\/a>, une entreprise genevoise sp\u00e9cialis\u00e9e dans la neuroth\u00e9rapeutique de pr\u00e9cision \u00e0 grande \u00e9chelle, a conclu un accord d\u00e9finitif pour un financement en actions de CHF 8 millions avec <a href=\"https:\/\/neuro.io\/\">Neuro.io Group<\/a>. Par cette op\u00e9ration, Neuro.io acquerra une participation strat\u00e9gique dans la soci\u00e9t\u00e9.<\/p>\n\n\n\n<p>Les fonds soutiendront les priorit\u00e9s commerciales de MindMaze Therapeutics, notamment le renforcement de son empreinte aux \u00c9tats-Unis et le d\u00e9ploiement \u00e9largi de ses solutions de neuroth\u00e9rapeutique. Le financement est structur\u00e9 en deux tranches compos\u00e9es d&rsquo;achats d&rsquo;actions propres et d&rsquo;obligations convertibles obligatoires, qui devraient \u00eatre converties en pr\u00e8s de 30 millions d&rsquo;actions ordinaires au cours des douze mois suivants, renfor\u00e7ant le bilan de l&rsquo;entreprise dans sa phase de mont\u00e9e en puissance.<\/p>\n\n\n\n<p>Parall\u00e8lement au financement, les deux parties ont sign\u00e9 une lettre d&rsquo;intention pour explorer diverses opportunit\u00e9s strat\u00e9giques, dont un potentiel rapprochement. Les discussions devraient porter sur la combinaison de la plateforme de neuroth\u00e9rapeutique cliniquement valid\u00e9e de MindMaze Therapeutics avec les capacit\u00e9s d&rsquo;IA et de calcul de Neuro.io ax\u00e9es sur la sant\u00e9, en vue de d\u00e9velopper et d\u00e9ployer des interventions bas\u00e9es sur l&rsquo;IA ciblant les troubles neurologiques.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MindMaze Therapeutics annonce un financement strat\u00e9gique en actions de CHF 8 millions aupr\u00e8s de Neuro.io Group pour d\u00e9velopper ses op\u00e9rations commerciales aux \u00c9tats-Unis et ouvrant la voie \u00e0 un potentiel rapprochement entre neuroth\u00e9rapeutique et intelligence artificielle.<\/p>\n","protected":false},"author":6,"featured_media":39091,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1179,1180,1148,1188,1239],"class_list":["post-39094","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-artificial-intelligence-fr-2","tag-digital-health-fr-2","tag-financing-fr-2","tag-healthcare-fr-2","tag-neuroscience-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MindMaze l\u00e8ve CHF 8 millions aupr\u00e8s de Neuro.io Group | GGBa<\/title>\n<meta name=\"description\" content=\"MindMaze Therapeutics annonce un financement strat\u00e9gique en actions de CHF 8 millions aupr\u00e8s de Neuro.io Group.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MindMaze l\u00e8ve CHF 8 millions aupr\u00e8s de Neuro.io Group | GGBa\" \/>\n<meta property=\"og:description\" content=\"MindMaze Therapeutics annonce un financement strat\u00e9gique en actions de CHF 8 millions aupr\u00e8s de Neuro.io Group.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-01T11:32:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-01T11:36:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2026\/06\/Mindmaze-GGBa-2026-1180x811-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"MindMaze l\u00e8ve CHF 8 millions pour d\u00e9ployer sa plateforme neuroth\u00e9rapeutique\",\"datePublished\":\"2026-06-01T11:32:11+00:00\",\"dateModified\":\"2026-06-01T11:36:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/\"},\"wordCount\":222,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/06\/Mindmaze-GGBa-2026-1180x811-1.png\",\"keywords\":[\"Artificial Intelligence\",\"Digital Health\",\"Financing\",\"Healthcare\",\"Neuroscience\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/\",\"name\":\"MindMaze l\u00e8ve CHF 8 millions aupr\u00e8s de Neuro.io Group | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/06\/Mindmaze-GGBa-2026-1180x811-1.png\",\"datePublished\":\"2026-06-01T11:32:11+00:00\",\"dateModified\":\"2026-06-01T11:36:05+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"MindMaze Therapeutics annonce un financement strat\u00e9gique en actions de CHF 8 millions aupr\u00e8s de Neuro.io Group.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/06\/Mindmaze-GGBa-2026-1180x811-1.png\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/06\/Mindmaze-GGBa-2026-1180x811-1.png\",\"width\":1180,\"height\":811,\"caption\":\"Illustration de la connectivit\u00e9 neuronale, refl\u00e9tant la mission de MindMaze Therapeutics : combiner des neuroth\u00e9rapies valid\u00e9es cliniquement aux capacit\u00e9s de l'IA pour traiter les troubles neurologiques.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MindMaze l\u00e8ve CHF 8 millions pour d\u00e9ployer sa plateforme neuroth\u00e9rapeutique\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MindMaze l\u00e8ve CHF 8 millions aupr\u00e8s de Neuro.io Group | GGBa","description":"MindMaze Therapeutics annonce un financement strat\u00e9gique en actions de CHF 8 millions aupr\u00e8s de Neuro.io Group.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/","og_locale":"fr_FR","og_type":"article","og_title":"MindMaze l\u00e8ve CHF 8 millions aupr\u00e8s de Neuro.io Group | GGBa","og_description":"MindMaze Therapeutics annonce un financement strat\u00e9gique en actions de CHF 8 millions aupr\u00e8s de Neuro.io Group.","og_url":"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2026-06-01T11:32:11+00:00","article_modified_time":"2026-06-01T11:36:05+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/06\/Mindmaze-GGBa-2026-1180x811-1.png","type":"image\/png"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"MindMaze l\u00e8ve CHF 8 millions pour d\u00e9ployer sa plateforme neuroth\u00e9rapeutique","datePublished":"2026-06-01T11:32:11+00:00","dateModified":"2026-06-01T11:36:05+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/"},"wordCount":222,"image":{"@id":"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/06\/Mindmaze-GGBa-2026-1180x811-1.png","keywords":["Artificial Intelligence","Digital Health","Financing","Healthcare","Neuroscience"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/","url":"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/","name":"MindMaze l\u00e8ve CHF 8 millions aupr\u00e8s de Neuro.io Group | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/06\/Mindmaze-GGBa-2026-1180x811-1.png","datePublished":"2026-06-01T11:32:11+00:00","dateModified":"2026-06-01T11:36:05+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"MindMaze Therapeutics annonce un financement strat\u00e9gique en actions de CHF 8 millions aupr\u00e8s de Neuro.io Group.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/06\/Mindmaze-GGBa-2026-1180x811-1.png","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/06\/Mindmaze-GGBa-2026-1180x811-1.png","width":1180,"height":811,"caption":"Illustration de la connectivit\u00e9 neuronale, refl\u00e9tant la mission de MindMaze Therapeutics : combiner des neuroth\u00e9rapies valid\u00e9es cliniquement aux capacit\u00e9s de l'IA pour traiter les troubles neurologiques."},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/mindmaze-leve-chf-8-millions-pour-deployer-sa-plateforme-neurotherapeutique\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"MindMaze l\u00e8ve CHF 8 millions pour d\u00e9ployer sa plateforme neuroth\u00e9rapeutique"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/39094","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=39094"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/39094\/revisions"}],"predecessor-version":[{"id":39096,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/39094\/revisions\/39096"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/39091"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=39094"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=39094"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=39094"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}